EZZ Life Science Holdings Limited (ASX:EZZ)
Australia
· Delayed Price · Currency is AUD 1.030
-0.055 (-5.07%)
Mar 9, 2026, 3:38 PM AEST
EZZ Life Science Holdings Market Cap
EZZ Life Science Holdings has a market cap or net worth of 48.48 million as of March 9, 2026. Its market cap has decreased by -48.87% in one year.
Market Cap
48.48M
Enterprise Value
33.93M
Revenue
61.40M
Ranking
n/a
PE Ratio
16.79
Stock Price
1.03
Market Cap Chart
Since March 3, 2021, EZZ Life Science Holdings's market cap has decreased from 48.72M to 48.48M, a decrease of -0.49%. That is a compound annual growth rate of -0.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 48.48M | -26.91% |
| Dec 31, 2025 | 66.33M | -54.20% |
| Dec 31, 2024 | 144.82M | 421.72% |
| Dec 29, 2023 | 27.76M | 73.11% |
| Dec 30, 2022 | 16.04M | -26.47% |
| Dec 31, 2021 | 21.81M | -55.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entropy Neurodynamics | 51.69M |
| Proteomics International Laboratories | 52.86M |
| Amplia Therapeutics | 56.44M |
| Neurizon Therapeutics | 57.29M |
| Prescient Therapeutics | 57.83M |
| Avecho Biotechnology | 44.08M |
| Imugene | 73.95M |
| Radiopharm Theranostics | 74.43M |